doi: 10.3727/096504010x12644422320582.
Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation
Affiliations
- PMID: 20441050
- DOI: 10.3727/096504010x12644422320582
Item in Clipboard
Lentivirus-mediated knockdown of cyclin Y (CCNY) inhibits glioma cell proliferation
Oncol Res.
2010.
Abstract
Cyclin Y (CCNY) is a novel cyclin and almost nothing is known about its expression level and role in human cancers. In the present study, we found that lentivirus-mediated RNA interference (RNAi) of CCNY significantly downregulated its expression level. More importantly, knockdown of CCNY inhibited cell proliferation, colony formation, and cell cycle progression in glioma cells. These data suggest that CCNY might play an important role in glioma tumorigenisis.
Similar articles
-
[Influence on cell proliferation by small interfering RNA of Cyclin Y expression in laryngeal cancer cells].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Sep;48(9):761-4. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013. PMID: 24330880 Chinese.
-
Lentivirus-mediated knockdown of tumor protein D52-like 2 inhibits glioma cell proliferation.Cell Mol Biol (Noisy-le-grand). 2014 May 11;60(1):39-44. Cell Mol Biol (Noisy-le-grand). 2014. PMID: 24842331
-
RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth.Oncol Rep. 2016 Nov;36(5):2793-2799. doi: 10.3892/or.2016.5126. Epub 2016 Sep 23. Oncol Rep. 2016. PMID: 27666310
-
Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.Neurol Res. 2014 Jul;36(7):659-65. doi: 10.1179/1743132813Y.0000000298. Epub 2013 Dec 19. Neurol Res. 2014. PMID: 24620959
-
Inhibition of Human Glioma Cell Proliferation Caused by Knockdown of Utrophin Using a Lentivirus-Mediated System.Cancer Biother Radiopharm. 2016 May;31(4):133-8. doi: 10.1089/cbr.2015.1939. Cancer Biother Radiopharm. 2016. PMID: 27183436
Cited by
-
Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma.Transl Oncol. 2021 Jan;14(1):100979. doi: 10.1016/j.tranon.2020.100979. Epub 2020 Dec 5. Transl Oncol. 2021. PMID: 33290989 Free PMC article.
-
The role of cyclin Y in normal and pathological cells.Cell Cycle. 2023 Apr;22(8):859-869. doi: 10.1080/15384101.2022.2162668. Epub 2022 Dec 28. Cell Cycle. 2023. PMID: 36576166 Free PMC article. Review.
-
Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in lower-grade glioma.Funct Integr Genomics. 2023 Mar 17;23(2):84. doi: 10.1007/s10142-023-01003-5. Funct Integr Genomics. 2023. Retraction in: Funct Integr Genomics. 2024 May 11;24(3):88. doi: 10.1007/s10142-024-01374-3. PMID: 36930242 Retracted. Review.
-
CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.J Exp Clin Cancer Res. 2022 Apr 21;41(1):149. doi: 10.1186/s13046-022-02362-w. J Exp Clin Cancer Res. 2022. PMID: 35449080 Free PMC article.
-
Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex.Exp Mol Med. 2019 Apr 16;51(4):1-17. doi: 10.1038/s12276-019-0242-2. Exp Mol Med. 2019. PMID: 30992425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources